Glass Lewis Recommends Stockholders Support Significant Change at Enhabit by Voting the WHITE Proxy Card “FOR” Three of AREX Capital’s Nominees
Glass Lewis Concludes That Support is Merited for AREX Nominees to Add “Fresh Perspectives and Relevant Expertise”
Two Leading Independent Proxy Advisory Firms Recognize That Boardroom Change is Urgently Needed at
AREX Managing Partner,
“We appreciate that another leading independent proxy advisory firm has recognized the value of having home health and hospice expertise on Enhabit’s Board and validated our case for significant boardroom change. We are pleased that Glass Lewis has recommended that stockholders vote for
In its report, Glass Lewis made the following observations regarding the need for boardroom change at
- “… [T]here is a valid case to be made for supporting at least incremental change to the Company's board, given the Company's financial underperformance relative to its closest peers, the Company's missteps in the strategic review process, and the relevant experience and expertise of the Dissident Nominees.”
- “… [T]he TSR of the Company has significantly lagged behind its closest industry peers and has trailed the average and median returns of the Proxy Peer Groups for most of the selected timeframes.”
- “… [T]he election of these three Dissident Nominees will facilitate the inclusion of fresh perspectives and relevant expertise…”
***
We remain open to constructive dialogue with the Company to reach a solution in the interest of all stockholders.
AREX encourages stockholders to vote for all seven of its highly qualified nominees on the WHITE Proxy Card at the upcoming Annual Meeting. AREX believes this will ensure that
Stockholders are encouraged to visit www.rehabEHAB.com for additional information and to download AREX’s comprehensive plan to turn around Enhabit’s operational performance: Rehabilitate
About AREX
1 Permission to use quotations from Glass Lewis was neither sought nor obtained.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240718155049/en/
Investor Contact
(212) 257-1311
rehabEHAB@saratogaproxy.com
Media Contact
(646) 386-0091
rehabEHAB@longacresquare.com
Source: